The European Medicines Agency's strategies to meet the challenges of Alzheimer disease
NATURE REVIEWS DRUG DISCOVERY(2015)
摘要
Regulatory agencies have a key role in facilitating the development of new drugs for Alzheimer disease, particularly given the challenges associated with early intervention. Here, we summarize the strategies of the European Medicines Agency to help address such challenges.
更多查看译文
关键词
Clinical trials, Drug regulation, Biomarkers, Drug development, Diseases of the nervous system
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要